Your browser doesn't support javascript.
loading
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.
Song, Shumei; Chen, Qiongrong; Li, Yuan; Lei, Guang; Scott, Ailing; Huo, Longfei; Li, Cordelia Y; Estrella, Jeannelyn Santiano; Correa, Arlene; Pizzi, Melissa Pool; Ma, Lang; Jin, Jiankang; Liu, Bin; Wang, Ying; Xiao, Lianchun; Hofstetter, Wayne L; Lee, Jeffrey H; Weston, Brian; Bhutani, Manoop; Shanbhag, Namita; Johnson, Randy L; Gan, Boyi; Wei, Shaozhong; Ajani, Jaffer A.
Afiliação
  • Song S; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA ssong@mdanderson.org jajani@mdanderson.org.
  • Chen Q; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Li Y; Pathology, Hubei Cancer Hospital, Wuhan, Hubei, China.
  • Lei G; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Scott A; Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Huo L; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Li CY; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Estrella JS; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Correa A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pizzi MP; Department of Thoracic & Cardio Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ma L; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jin J; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Liu B; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang Y; Department of Epigenet & Mol Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Xiao L; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hofstetter WL; Department of Statistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lee JH; Department of Thoracic & Cardio Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Weston B; Gastroenterology, Hepat & Nutri, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bhutani M; Gastroenterology, Hepat & Nutri, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shanbhag N; Gastroenterology, Hepat & Nutri, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Johnson RL; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gan B; Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wei S; Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ajani JA; Surgical Oncology, Hubei Cancer Hospital, Wuhan, Hubei, China.
Gut ; 70(12): 2238-2248, 2021 12.
Article em En | MEDLINE | ID: mdl-33487592
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Células-Tronco Neoplásicas / Neoplasias Esofágicas / Gossipol / Proteínas Proto-Oncogênicas c-bcl-2 / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Células-Tronco Neoplásicas / Neoplasias Esofágicas / Gossipol / Proteínas Proto-Oncogênicas c-bcl-2 / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article